Antitumor effect of sorafenib and mammalian target of rapamycin inhibitor in liver transplantation recipients with hepatocellular carcinoma recurrence-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antitumor effect of sorafenib and mammalian target of rapamycin inhibitor in liver transplantation recipients with hepatocellular carcinoma recurrence

Published:2018-07 Issue:7 Volume:24 Page:932-945
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Jung Dong-Hwan¹,Tak Eunyoung²,Hwang Shin¹,Song Gi-Won¹,Ahn Chul-Soo¹,Kim Ki-Hun¹,Moon Deok-Bog¹,Ha Tae-Yong¹,Park Gil-Chun¹,Ryoo Baek-Yeol³,Lee Kyung Jin²,Kim Nayoung²,Kwon Jae-Hyeon¹,Jwa Eun-Kyoung¹,Lee Sung-Gyu¹

Affiliation:

1. Division of Hepatobiliary Surgery and Liver Transplantation, Departments of Surgery

2. Asan Institute of Life Sciences, Asan Medical Center; University of Ulsan College of Medicine; Seoul Korea

3. Oncology

Funder

Basic Science Research Program

National Research Foundation of Korea

Ministry of Science, ICT

Future Planning

Research Fund from Korean Society for Transplantation

National Institute of Diabetes and Digestive and Kidney Diseases

National Heart, Lung, and Blood Institute

American Diabetes Association

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/lt.25191/fullpdf

Reference40 articles.

1. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report;Clavien;Lancet Oncol,2012

2. Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience;Mazzaferro;Liver Transpl,2011

3. Liver transplantation for hepatocellular carcinoma;Mazzaferro;Ann Surg Oncol,2008

4. Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center;Lee;Liver Transpl,2008

5. Risk-based long-term screening for hepatocellular carcinoma recurrence after living donor liver transplantation;Hwang;Transplant Proc,2013

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver transplantation for hepatocellular carcinoma: Current status in Hong Kong, China;Hepatobiliary & Pancreatic Diseases International;2024-09

2. Recipient blood group does not affect hepatocellular carcinoma recurrence after living donor liver transplantation in Korea;Surgery Today;2024-06-13

3. Liver transplantation and liver resection as alternative treatments for primary hepatobiliary and secondary liver tumors: Competitors or allies?;Hepatobiliary & Pancreatic Diseases International;2023-12

4. Insights into the history and tendency of liver transplantation for liver cancer: a bibliometric-based visual analysis;International Journal of Surgery;2023-10-04

5. The Role of mTOR Inhibitors after Liver Transplantation for Hepatocellular Carcinoma;Current Oncology;2023-06-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3